{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-084180","form_type":"8-K","ticker":"SMNR","cik":"0001913577","company_name":"Semnur Pharmaceuticals, Inc.","filed_at":"2025-09-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.577616+00:00","generated_at":"2026-05-17T08:22:04.436039+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Shareholders approve merger with Semnur Pharmaceuticals at September 3 meeting","bullets":["All 9 proposals, including business combination with Semnur, approved by 94.08% quorum.","Domestication from Cayman Islands to Delaware and amended charter/bylaws approved.","New board of directors elected: Jaisim Shah, Henry Ji, Jay Chun, Dorman Followwill, Yue Alexander Wu.","Issuance of >20% of Denali shares and conversion of Semnur options into New Semnur options approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-084180","json":"https://secwatch.observer/filing/0001213900-25-084180.json","markdown":"https://secwatch.observer/filing/0001213900-25-084180.md","text":"https://secwatch.observer/filing/0001213900-25-084180.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1913577/000121390025084180/0001213900-25-084180-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1913577/000121390025084180/ea0255814-8k_denali.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:22:04.436039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}